RxDoctor Payments Data

Eric Lutzwick, NP

Nurse Practitioner · Bismarck, NDNPI 1568877827

Payments from drug & device makers

$446in general payments, 2019–2025

Across 29 payments — averaging $15.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$105
  • Biohaven Pharmaceutical Holding Company Ltd.$56
  • Astellas Pharma US Inc$50
  • Novartis$38
  • Sanofi-aventis U.S. LLC$33
  • Amgen$30
  • plus $135 from 7 others

What the payments were for

  • Food & beverage$446100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$446 in reported general payments places this provider in the 70th percentile of 455 nurse practitioner providers in North Dakota.

See all nurse practitioner providers in North Dakota

Medicare billing

Part B allowed, 2024
$125,883
Medicare patients
428
Services billed
2,707

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban146$81,329
MounjaroTirzepatide64$68,422
JardianceEmpagliflozin30$29,727
OzempicSemaglutide28$28,790
XareltoRivaroxaban35$25,914
TrulicityDulaglutide11$9,786
JanuviaSitagliptin Phosphate15$8,984
Spiriva RespimatTiotropium Bromide17$8,656
EffientPrasugrel Hcl12$6,145
LinzessLinaclotide11$6,135
Lantus SolostarInsulin Glargine,hum.Rec.Anlog50$4,733
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$3,529
Rosuvastatin Calcium235$2,640
Metoprolol Succinate163$2,510
Esomeprazole Magnesium66$2,500

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$24$38,38347 claims
Novo NordiskOzempic$105$28,79028 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 455 nurse practitioner providers in North Dakota.

Other nurse practitioner in Bismarck

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →